non-financial development institution
major organizer of congress and exhibition events
RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
A Substantive Dialogue Between Global Pharmaceutical Players and BRICS Economies on the Rules of Fair and Equitable Competition
6 June 2019
Aleksey Ivanov
Director, Institute of Law and Development HSE - Skolkovo, Director, BRICS Antimonopoly Centre, National Research University Higher School of Economics
Anna Numerova
Partner, Egorov Puginsky Afanasiev & Partners
Speakers and experts
Marwan Aqar
General Director, MSD Pharmaceuticals; Managing Director, MSD Russia, Belarus and Kazakhstan
Tembinkosi Bonakele
Commissioner, Competition Commission of South Africa
Matthias Wernicke
General Manager, Merck Biopharma Russia and CIS
Dennis Davis
Judge, President, Competition Appeals Court of South Africa
Hans Duijf
Vice-President, Russia and Belarus, Novo Nordisk
Natalia Kolerova
General Manager, Oncology Department, Russia, Ukraine and CIS, Novartis AG
Payal Malik
Economics Adviser, Head of the Economics Division, Competition Commission of the Republic of India
Dmitry Morozov
General Director, BIOCAD
Irina Panarina
General Manager, Russia and Eurasia, AstraZeneca
Vikram Singh Punia
President, Pharmasyntez
Andrey Tsarikovskiy
Stats-Secretary, Deputy Head of the FAS Russia
Zhao Chunlei
Director of Monopoly Agreement Office, Anti-Monopoly Bureau, State Administration for Market Regulation of People’s Republic of China (SAMR)